|
Originally published In Press as doi:10.1074/jbc.M201375200 on October 29, 2002
J. Biol. Chem., Vol. 278, Issue 1, 672-678, January 3, 2003
1-Adrenergic Receptor Subtypes Differentially
Control the Cell Cycle of Transfected CHO Cells through a
cAMP-dependent Mechanism Involving p27Kip1*
Katsushi
Shibata,
Susumu
Katsuma,
Takaaki
Koshimizu,
Hitomi
Shinoura,
Akira
Hirasawa,
Akito
Tanoue, and
Gozoh
Tsujimoto
From the Department of Molecular and Cell Pharmacology, National
Center for Child Health and Development Research Institute, 3-35-31 Taishido, Setagaya-Ku, Tokyo 154-8567, Japan
Three distinct subtypes of
1-adrenergic receptors ( 1A-,
1B-, and 1D-AR) play a prominent role in
cell growth. However, little is known about subtype-specific effects on
cell proliferation. The activation of 1A- or
1B-AR inhibits serum-promoted cell proliferation,
whereas 1D-AR activation does not show such an inhibitory effect. Notably, cell-cycle progression was blocked at
G1/S transition after activation of
1A/ 1B-AR but not of 1D-AR. In agreement with the differential cell proliferation effect, cAMP
production was increased after activation of
1A/ 1B-AR but not 1D-AR,
whereas all 1-AR subtypes are associated with inositol 1,4,5-trisphosphate production and mitogen-activated protein kinase activation in a similar fashion. Furthermore, the serum-induced reduction in the levels of the cyclin-dependent kinase
inhibitor, p27Kip1, was blocked after activation of
1A/ 1B-AR but not 1D-AR.
These results show that 1-AR subtypes differentially
activate the cAMP/p27Kip1 pathway and thereby have differential
inhibitory effects on cell proliferation. Subtype-dependent
effects should be taken into consideration when assessing the
physiological response of native cells where 1-AR
subtypes are generally co-expressed.
*
This work was supported in part by research grants from the
Scientific Fund of the Ministry of Education, Science, and Culture of
Japan; the Japan Health Science Foundation and Ministry of Human Health
and Welfare; the Organization for Pharmaceutical Safety and Research;
and a grant for Liberal Harmonious Research Promotion System from the
Ministry of Education, Culture, Sports, Science and Technology of
Japan.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 81-3-3419-1252;
Fax: 81-3-3419-1252; E-mail: gtsujimoto@nch.go.jp.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Fujiwara, M. Hiroyama, A. Sanbe, T. Aoyagi, J.-i. Birumachi, J. Yamauchi, G. Tsujimoto, and A. Tanoue
Insulin hypersensitivity in mice lacking the V1b vasopressin receptor
J. Physiol.,
October 1, 2007;
584(1):
235 - 244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Michelotti, D. M. Brinkley, D. P. Morris, M. P. Smith, R. J. Louie, and D. A. Schwinn
Epigenetic regulation of human {alpha}1d-adrenergic receptor gene expression: a role for DNA methylation in Sp1-dependent regulation
FASEB J,
July 1, 2007;
21(9):
1979 - 1993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zhang, J. Bai, A. S. Undie, C. Bergson, and M. S. Lidow
D1 Dopamine Receptor Regulation of the Levels of the Cell-cycle-controlling Proteins, Cyclin D, P27 and Raf-1, in Cerebral Cortical Precursor Cells is Mediated Through cAMP-independent Pathways
Cereb Cortex,
January 1, 2005;
15(1):
74 - 84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Gonzalez-Cabrera, T. Shi, J. Yun, D. F. McCune, B. R. Rorabaugh, and D. M. Perez
Differential Regulation of the Cell Cycle by {alpha}1-Adrenergic Receptor Subtypes
Endocrinology,
November 1, 2004;
145(11):
5157 - 5167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-a. Koshimizu, G. Tsujimoto, A. Hirasawa, Y. Kitagawa, and A. Tanoue
Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human {alpha}1D- and {alpha}1B-adrenergic receptors
Cardiovasc Res,
September 1, 2004;
63(4):
662 - 672.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|